Cosmos Health Strikes Deal to Expand Nutraceuticals in Qatar

Cosmos Health Inc. Announced a distribution agreement with International Medical Company (IMC) on June 26, 2026, to expand the availability of its nutraceutical products in Qatar. The partnership aims to introduce Cosmos Health's specialized health supplements into Qatari markets through IMC's distribution network. This strategic move specifically targets the expansion of Cosmos Health's Sky Premium Life® line of nutraceuticals and food supplements within the State of Qatar. Following the agreement, IMC placed an initial purchase order totaling 31,000 units of Cosmos Health's nutraceuticals. This order marks the first step in the collaboration, making Cosmos Health products accessible to consumers in the region and signaling a significant entry into the Qatari health and wellness sector. The collaboration is poised to leverage IMC's extensive market presence to establish a strong foothold for Cosmos Health's diverse product portfolio.

IMC's Dominant Market Position

International Medical Company (IMC) was established in 1998, developing a significant presence in the Qatari market over more than two decades. Founded with a vision to serve the healthcare needs of the region, IMC has grown to become a prominent player in pharmaceutical and consumer health product distribution. The company operates with a substantial workforce, employing over 1,400 individuals across its specialized Sales & Marketing, Pharmacy, and Consumer divisions. This extensive team supports the distribution and retail operations within the region, ensuring full market coverage and efficient service delivery.

A key component of IMC's market dominance is its retail division, Kulud Pharmacies. Kulud Pharmacies is recognized as the largest pharmacy chain in Qatar, providing a wide array of health and wellness products to consumers. The chain maintains a full product portfolio, offering more than 12,000 distinct items to meet diverse customer needs. With over 130 branches strategically located across Qatar, Kulud Pharmacies offers unparalleled accessibility to consumers throughout the country. This expansive reach and product offering position IMC as a major player in Qatar's health sector, making it an ideal partner for Cosmos Health's expansion efforts. The established infrastructure and broad consumer base of Kulud Pharmacies are expected to significantly accelerate the market penetration of Cosmos Health's nutraceutical offerings.

Distribution and Operational Scope

International Medical Company (IMC) will oversee all critical operational functions for Cosmos Health products within Qatar. These responsibilities encompass sales and marketing initiatives, managing regulatory affairs, and handling all aspects of logistics, supply chain management, and distribution throughout the country. IMC's full approach ensures that Cosmos Health products will be introduced and sustained in the Qatari market with full compliance and operational efficiency. This includes navigating the local regulatory landscape, which is key for the successful entry of health supplements. The integrated management of these functions by IMC shows the depth of this partnership and its commitment to long-term success.

Cosmos Health Inc. Maintains a significant operational footprint across Europe, supporting its global distribution efforts. The company operates offices and distribution centers in multiple locations within Greece, specifically in the cities of Thessaloniki and Athens. Additionally, Cosmos Health has established an office and distribution center in Harlow, United Kingdom, further facilitating its international reach and product accessibility. This strong European infrastructure enables Cosmos Health to efficiently manage its supply chain and global distribution network, ensuring timely delivery of products to partners like IMC. These operational hubs are integral to the company's strategy for expanding its brand presence in new markets worldwide.

Market Reaction and Financials

Cosmos Health (NASDAQ:COSM) shares declined 6.85% following the announcement of its distribution agreement with International Medical Company. The stock is currently trading at $0.17 per share. This market reaction resulted in an approximate valuation impact of -$788K for the company. Despite the immediate market dip, the company's long-term strategy focuses on global expansion and brand building. Cosmos Health Inc. Was incorporated in 2009 in Nevada, establishing its corporate foundation prior to its public trading. The company has since grown its portfolio and market presence, aiming to solidify its position in the health and wellness industry.

Strategic Expansion Outlook

The agreement specifically targets the expansion of Cosmos Health's Sky Premium Life® line of nutraceuticals and food supplements within the State of Qatar. Cosmos Health owns several brands, including Sky Premium Life®, Mediterranation®, bio-bebe®, C-Sept®, and C-Scrub®. This strategic move leverages International Medical Company's extensive retail network. Kulud Pharmacies, a key part of IMC's operations, has over 130 branches across Qatar, providing a significant platform for the new products. This broad reach is expected to enhance the market penetration of Cosmos Health's nutraceutical offerings, making its specialized health supplements readily available to a wide consumer base. The partnership represents a key step in Cosmos Health's broader strategy to expand its international footprint and capitalize on the growing demand for high-quality nutraceuticals in the Middle East.